Track topics on Twitter Track topics that are important to you
BeiGene, a Beijing innovative cancer biotech, raised a spectacular $750 million in a secondary offering of its shares. The price of the shares ended the session 13% higher after the funding was announ...
BeiGene (Beijing) Co. Ltd. (immuno-oncology) netted $710.6mm through the public sale of 7.4mm American Depositary Shares (representing 96.5mm common) priced at $101 per ADS. Proceeds will support gene...
BeiGene (Beijing) Co. Ltd. (immuno-oncology) netted $758mm through the public sale of 7.9mm American Depositary Shares (representing 103mm common; including the overallotment) priced at $101 per ADS. ...
For tislelizumab, BeiGene’s investigational anti-PD-1 antibody
BEIJING, China and CAMBRIDGE, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovativ...
In a hookup with the German drugmaker, BeiGene gets a boost for tislelizumab production.
BeiGene has signed an exclusive license agreement for the development, manufacturing and commercialization…
Beijing's BeiGene has launched Vidaza® in China. Vidaza is a nucleoside metabolic inhibitor that is approved in China for patients with myelodysplastic syndrome (MDS), acute myeloid leukemia (AML)...
The purpose of this research study is to look at the effects, good or bad, of TetMYB Vaccine in combination with BGB-A317 in patients with advanced or metastatic solid cancers (including c...
BeiGene is an innovative Chinese oncology R&D company focusing on discovering, developing and commercializing targeted and immune-oncology therapeutics. With a team of 150 scienti...
BeiGene is an innovative, clinical-stage Chinese oncology R&D company focused on discovering, developing and commercializing targeted and immune-oncology therapeutics through a no...
BeiGene is a Chinese life sciences biotechnology company based in the Zhongguancun Life Science Park in Beijing that is focused on discovering and developing innovative oncology d...
We have published hundreds of BeiGene Ltd. news stories on BioPortfolio along with dozens of BeiGene Ltd. Clinical Trials and PubMed Articles about BeiGene Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BeiGene Ltd. Companies in our database. You can also find out about relevant BeiGene Ltd. Drugs and Medications on this site too.
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...
Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers) - Mouth cancer can develop on the lip, the tongue, the floor...